Source - SMW
Andrew Witty, Chief Executive Officer, has re-invested 3,156 shares in the company on the 18th October 2016 at a price of 1700.00p. The Director now holds 567,850 shares.




Director deals data provided by www.directorsholdings.com

Related Charts

GlaxoSmithKline (GSK)

-8.25p (-0.57%)
delayed 08:28AM